DanS.GombosMDFACS

Ocular Oncology

Professor & Chief, Section of Ophthalmology MD Anderson Cancer Center

Dr. Gombos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Pennsylvania Health System/Scheie Eye InstituteChief Residency, Ophthalmology, 1997 - 1998
University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 1995 - 1998
Stanford University School of MedicineClass of 1994

PubMed

3 citations
Multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing.
Sarah B Pike, Mark W Reid, Chen-Ching Peng, Christina Chang, Benjamin Y Xu
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2025-02-01
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.
Akshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski, Senthil Damodaran, Yan Wang
NPJ Breast Cancer. 2025-01-26
2 citations
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen
Ophthalmology. 2024-11-01

Lectures

Final Results of Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Uveal Melanoma Survivor: Specialized Treatment Saved Both My Eyesight and My LifeDecember 4th, 2019
Genetic Testing Recommended for Children Considered at Risk for Most Common Eye CancerOctober 18th, 2017